Form 8-K - Current report:
SEC Accession No. 0001193125-25-244262
Filing Date
2025-10-21
Accepted
2025-10-21 07:05:33
Documents
14
Period of Report
2025-10-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d43495d8k.htm   iXBRL 8-K 24282
2 EX-99.1 d43495dex991.htm EX-99.1 14238
6 GRAPHIC g43495g1021002347702.jpg GRAPHIC 2866
  Complete submission text file 0001193125-25-244262.txt   157260

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qttb-20251021.xsd EX-101.SCH 2516
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qttb-20251021_lab.xml EX-101.LAB 17205
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qttb-20251021_pre.xml EX-101.PRE 10793
16 EXTRACTED XBRL INSTANCE DOCUMENT d43495d8k_htm.xml XML 3577
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38433 | Film No.: 251405350
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)